Related Experiment Video
Updated: Jul 7, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Combination of biomarkers to predict mortality in elderly patients with myocardial infarction
Fabiola Olivieri1, Liana Spazzafumo, Roberto Antonicelli
1Center of Genetic and Molecular Biology, Cardiology-CCU Unit, Center of Statistics, Center of Immunology and Nutrigenomics, Center of Citology, Italian National Research Centers on Aging (I.N.R.C.A.), Ancona, Italy. b.molecolare@inrca.it
Insights
Elderly patients with Acute Myocardial Infarction (AMI) face high mortality. Combining C-reactive protein (CRP) and total homocysteine (tHcy) with vitamin levels improves heart mortality risk prediction.
Area of Science:
- Cardiology
- Biomarkers
- Geriatrics
Background:
- Elderly patients with Acute Myocardial Infarction (AMI) exhibit the highest mortality rates.
- Accurate risk stratification is crucial for managing this high-risk population.
Purpose of the Study:
- To enhance mortality risk stratification in elderly AMI patients.
- To evaluate the combined predictive value of various biomarkers, including genetic markers.
Main Methods:
- A one-year follow-up study was conducted on 250 elderly AMI patients.
- Concurrent evaluation of plasma levels for total homocysteine (tHcy), folate, vitamin B12, and C-reactive protein (CRP).
Main Results:
- High tHcy, low folate and vitamin B12, and elevated CRP levels identified the highest risk for cardiac mortality (RR=4.20).
- Conversely, low tHcy, high folate and vitamin B12, and low CRP levels indicated a lower risk pathway.
Conclusions:
- Concomitant elevation of CRP and tHcy, coupled with low folate and vitamin B12 levels, is a significant predictor of cardiac mortality in elderly AMI patients.
- This biomarker combination offers improved risk stratification capabilities.
Objective:
The elderly subjects affected by Acute Myocardial Infarction (AMI) have the highest risk of mortality. Our study was designed to improve the capability of mortality risk stratification in elderly AMI patients through the concurrent evaluations of different biomarkers, including genetic markers.
Methods And Results:
One-year follow-up study was performed in 250 elderly AMI patients. The combination of high total Homocysteine (tHcy), low folate and vitamin B12 plasma levels (18.0+/-9.0 micromol/l; 4.4+/-1.2 ng/ml; 404.2+/-287.5 pg/ml, respectively) and elevated CRP plasma levels (> or =6 mg/dl) identify the highest-risk pathway of heart mortality (RR=4.20, IC 95% 1.62-10.89, P<0.002) with respect to the combination of low total tHcy, high folate and vitamin B12 plasma levels (12.4+/-5.2 micromol/l; 8.9+/-2.5 ng/ml; 546.9+/-379.8 pg/ml, respectively) and low CRP plasma levels (<6 mg/dl).
Conclusion:
In elderly AMI patients the concomitant elevation of CRP and tHcy, associated with folate and vitamin B12 low levels, could be considered a significant predictive heart mortality risk factor.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies